Streetbeat News

Products Services

GOVX

GeoVax has received a notice of allowance for patent application No. 17/726,254 titled 'Compositions And Methods For Generating An Immune Response To Treat Or Prevent Malaria'. The patent covers a multiple component vaccine for both prevention and treatment of malaria.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 1:02 pm

INDI

Indie Semiconductor (NASDAQ:INDI) has launched the world's first fully integrated 240 GHz radar front-end silicon transceiver. The device is expected to enhance safety within vehicle cabins and revolutionize industrial monitoring applications. The company is sampling lead partners now, with production ramp slated for 2H 2024. Mordor Intelligence estimates the industrial terahertz frequency applications market, which the new device can address, will be a $1.8 billion opportunity by 2028.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 1:02 pm

QUIK

QuickLogic and YorChip have partnered to develop the industry's first UCIe-compatible FPGA chiplet ecosystem. The low-power, cost-effective integration is aimed at edge IoT and AI/ML markets.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 1:00 pm

META

WhatsApp, a messaging platform owned by Meta Platforms Inc., has introduced a new feature that allows users to share videos in high-definition (HD) 720p resolution, an upgrade from the previous 480p option. The feature is currently being rolled out gradually to both iOS and Android users. The process to share HD videos involves updating the app, selecting a video to share, choosing the video quality, reviewing the file size, and then sharing the video. All videos shared, including HD ones, are end-to-end encrypted for privacy and security.

Portfolio Pulse from Benzinga Neuro

August 28, 2023 | 12:59 pm

ABBV

AbbVie has submitted regulatory applications to the FDA and EMA for its drug Risankizumab, used in the treatment of ulcerative colitis. The submissions are backed by two Phase 3 clinical trials demonstrating the drug's effectiveness and safety. Risankizumab is currently approved by the FDA and EMA for Crohn's disease, psoriatic arthritis, and psoriasis.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:46 pm

SBET

SharpLink Gaming Ltd. (NASDAQ:SBET) CEO Rob Phythian issued a letter to shareholders outlining the company's growth strategies and key performance indicators. The company aims to have a profound impact on the U.S. sports betting industry by improving methods for reaching and converting sports fans into sports bettors. SharpLink has focused on acquiring an affiliate marketing company, completing a merger with SportsHub, and expanding its technology development team. The company's internal KPIs align with each component of its C4 solution: Connect, Collect, Convert, and Capitalize. SharpLink is licensed to operate in 24 U.S. states, the District of Columbia, Puerto Rico, and Ontario, Canada.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:38 pm

TTOO

T2 Biosystems, Inc. (NASDAQ:TTOO) has praised the U.S. Centers for Disease Control and Prevention's (CDC) new Hospital Sepsis Program Core Elements, aimed at improving sepsis programs and survival rates in U.S. hospitals. T2 Biosystems' products, including the T2Dx® Instrument, the T2Bacteria® Panel, and the T2Candida® Panel, are the first and only FDA-cleared products able to detect sepsis-causing pathogens directly from whole blood in 3-5 hours. The company's products identified sepsis-causing pathogens 77 hours faster than blood culture-based protocols, according to a meta-analysis of 14 controlled studies.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:37 pm

PRZO

ParaZero Technologies will present its drone safety systems at the International Drone Show. The company's solutions aim to enhance the safety of drone operations in urban environments.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:37 pm

NAOV

NanoVibronix, Inc. (NASDAQ:NAOV) has applied for inclusion of its UroShield products in the National Health Service (NHS) Prescription Services' Drug Tariff in the UK. If approved, the listing would enable reimbursement and increased distribution for NHS patients. The company's CEO, Brian Murphy, believes that the inclusion would allow UroShield technology to be reimbursed and gain broader distribution through pharmacies.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:37 pm

ATIF

ATIF Holdings Limited's IPO service client Solarever launched two new electric vehicles, the E-TUS and the E-WAN, in Mexico City. Solarever, a renewable energy company, is making strides in photovoltaic power generation, energy storage, charging, and energy trading. ATIF's President, Chairman of the Board and CEO, Mr. Liu Jun, congratulated Solarever on the new car launch.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:34 pm